Profile
Sebastien Bolze was the founder and the Chief Operating Officer & Executive Vice President of Poxel SA, a company founded in 2009.
Dr. Bolze also held the position of Global Head-Preclinical Candidate Selection Unit at Solvay Pharmaceuticals, Inc. from 2006 to 2009.
Prior to that, he was the Head-ADME Department at Fournier Pharma SA from 2003 to 2006.
Dr. Bolze received a doctorate degree from the University of Lyon.
Former positions of Sebastien Bolze
| Companies | Position | End |
|---|---|---|
Solvay Pharmaceuticals, Inc.
Solvay Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 2008-12-31 |
Fournier Pharma SA
Fournier Pharma SA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 2005-12-31 |
Merck Santé SASU
Merck Santé SASU Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Corporate Officer/Principal | 2002-12-31 |
| POXEL | Founder | - |
Training of Sebastien Bolze
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Poxel SA
Poxel SA Pharmaceuticals: MajorHealth Technology Operates as clinical-stage biopharmaceutical company, focuses on the development of novel treatments for serious chronic diseases | Health Technology |
Solvay Pharmaceuticals, Inc.
Solvay Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Fournier Pharma SA
Fournier Pharma SA Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
University of Lyon
University of Lyon Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Merck Santé SASU
Merck Santé SASU Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
- Stock Market
- Insiders
- Sebastien Bolze
















